TABLE 1

Daily Reporting Ratio and Excess Risk of Intussusception After RotaTeq (RV5) Using the SCRI Analysis for VAERS Data, by Dose Number

Dose No.0–6 d After RV5 Vaccination
3–6 d0–2 dDRR (95% CI)P ValueExcess Risk per 100 000 Infantsa (95% CI)Excess Cases in the US per Yeara Related to Rotavirus Vaccine (95% CI)
150103.75 (1.90 to 7.39)<0.0010.74 (0.24 to 1.71)30.1 (9.8 to 69.9)
242221.43 (0.85 to 2.40)0.10.21 (–0.07 to 0.68)8.3 (–2.9 to 26.9)
319190.75 (0.40 to 1.42)0.3−0.16 (–0.38 to 0.27)−5.5 (–13.2 to 9.3)
Total0.79 (–0.04 to 1.62)33 (0 to 66)